Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
14.86
-0.04 (-0.27%)
Apr 24, 2025, 2:45 PM CST
Shenzhen YHLO Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2019 - 2020 |
Cash & Equivalents | 494.95 | 464.97 | 490.59 | 1,251 | 478.85 | 232.36 | Upgrade
|
Short-Term Investments | - | - | 143.6 | 68.57 | - | - | Upgrade
|
Trading Asset Securities | 51.96 | 69.59 | 76.66 | 114.16 | 16.15 | - | Upgrade
|
Cash & Short-Term Investments | 546.91 | 534.57 | 710.85 | 1,433 | 495 | 232.36 | Upgrade
|
Cash Growth | -16.28% | -24.80% | -50.40% | 189.56% | 113.03% | 54.21% | Upgrade
|
Accounts Receivable | 540.33 | 523.85 | 414.19 | 346.38 | 254.43 | 213.6 | Upgrade
|
Other Receivables | 30.06 | 24.08 | 48.11 | 66.2 | 21.48 | 9.43 | Upgrade
|
Receivables | 570.39 | 547.93 | 462.3 | 412.58 | 275.91 | 223.03 | Upgrade
|
Inventory | 655.71 | 670.77 | 634.5 | 569.54 | 363.81 | 298.16 | Upgrade
|
Other Current Assets | 241.24 | 258.49 | 43.08 | 79.72 | 43.34 | 40.32 | Upgrade
|
Total Current Assets | 2,014 | 2,012 | 1,851 | 2,495 | 1,178 | 793.88 | Upgrade
|
Property, Plant & Equipment | 1,742 | 1,735 | 1,371 | 1,044 | 672.07 | 425.35 | Upgrade
|
Long-Term Investments | 276.02 | 358.17 | 260.91 | 302.82 | 75.42 | - | Upgrade
|
Goodwill | 5.29 | 5.29 | 5.29 | 5.29 | - | - | Upgrade
|
Other Intangible Assets | 177.35 | 182.88 | 188.98 | 210.07 | 103.78 | 35.75 | Upgrade
|
Long-Term Accounts Receivable | - | - | - | - | 3.76 | 3.99 | Upgrade
|
Long-Term Deferred Tax Assets | 40.39 | 44.01 | 47.68 | 50.57 | 16.81 | 13.53 | Upgrade
|
Long-Term Deferred Charges | 27.63 | 26.97 | 43.12 | 36.15 | 22.87 | 25.05 | Upgrade
|
Other Long-Term Assets | 46.07 | 51 | 37.89 | 69.9 | 65.05 | 26.09 | Upgrade
|
Total Assets | 4,329 | 4,415 | 3,806 | 4,214 | 2,138 | 1,324 | Upgrade
|
Accounts Payable | 241.48 | 295.35 | 203.81 | 307.76 | 137.6 | 73.74 | Upgrade
|
Accrued Expenses | 100.36 | 96.92 | 145.99 | 211.11 | 54.88 | 37.06 | Upgrade
|
Short-Term Debt | 292.72 | 292.32 | 171.07 | 279.36 | 150.82 | 302 | Upgrade
|
Current Portion of Long-Term Debt | 24.88 | 25.64 | - | - | - | - | Upgrade
|
Current Portion of Leases | - | - | 1.07 | 5.05 | 4.73 | 4.81 | Upgrade
|
Current Income Taxes Payable | 13.05 | 48.17 | 13.27 | 75.73 | 12.27 | 15.16 | Upgrade
|
Current Unearned Revenue | 171.09 | 183.32 | 183.51 | 528.61 | 111.09 | 58.94 | Upgrade
|
Other Current Liabilities | 104.85 | 115.99 | 122.56 | 126.24 | 40.79 | 28.94 | Upgrade
|
Total Current Liabilities | 948.43 | 1,058 | 841.28 | 1,534 | 512.17 | 520.65 | Upgrade
|
Long-Term Debt | 593.93 | 585.44 | 381.89 | 183.9 | 73.26 | - | Upgrade
|
Long-Term Leases | 3.18 | 2.39 | 3.57 | 5.24 | 4.89 | 8.22 | Upgrade
|
Long-Term Unearned Revenue | 61.2 | 62.52 | 36.7 | 29.75 | 33.25 | 30.8 | Upgrade
|
Long-Term Deferred Tax Liabilities | 4.31 | 4.54 | 9.06 | 15.88 | 0.02 | - | Upgrade
|
Other Long-Term Liabilities | 1.23 | 0.74 | - | - | - | - | Upgrade
|
Total Liabilities | 1,612 | 1,713 | 1,273 | 1,769 | 623.59 | 559.67 | Upgrade
|
Common Stock | 570.43 | 570.27 | 568.13 | 567 | 405 | 364 | Upgrade
|
Additional Paid-In Capital | 483.29 | 480.36 | 432.24 | 389.51 | 525.03 | 13.24 | Upgrade
|
Retained Earnings | 1,702 | 1,692 | 1,546 | 1,447 | 595.8 | 391.05 | Upgrade
|
Comprehensive Income & Other | 15.98 | 14.38 | 13.53 | 13.84 | -0.12 | -0.5 | Upgrade
|
Total Common Equity | 2,772 | 2,757 | 2,560 | 2,417 | 1,526 | 767.79 | Upgrade
|
Minority Interest | -55.11 | -55.32 | -26.27 | 28.1 | -11.49 | -3.81 | Upgrade
|
Shareholders' Equity | 2,717 | 2,702 | 2,534 | 2,445 | 1,514 | 763.98 | Upgrade
|
Total Liabilities & Equity | 4,329 | 4,415 | 3,806 | 4,214 | 2,138 | 1,324 | Upgrade
|
Total Debt | 914.71 | 905.79 | 557.6 | 473.55 | 233.69 | 315.03 | Upgrade
|
Net Cash (Debt) | -367.8 | -371.22 | 153.25 | 959.74 | 261.31 | -82.67 | Upgrade
|
Net Cash Growth | - | - | -84.03% | 267.28% | - | - | Upgrade
|
Net Cash Per Share | -0.66 | -0.65 | 0.27 | 1.69 | 0.48 | -0.16 | Upgrade
|
Filing Date Shares Outstanding | 507.4 | 570.27 | 568.13 | 567 | 567 | 509.6 | Upgrade
|
Total Common Shares Outstanding | 507.4 | 570.27 | 568.13 | 567 | 567 | 509.6 | Upgrade
|
Working Capital | 1,066 | 954.06 | 1,009 | 961.27 | 665.88 | 273.23 | Upgrade
|
Book Value Per Share | 5.46 | 4.83 | 4.51 | 4.26 | 2.69 | 1.51 | Upgrade
|
Tangible Book Value | 2,589 | 2,569 | 2,366 | 2,202 | 1,422 | 732.04 | Upgrade
|
Tangible Book Value Per Share | 5.10 | 4.50 | 4.16 | 3.88 | 2.51 | 1.44 | Upgrade
|
Buildings | - | - | 342.69 | 322.37 | 222.47 | 163.14 | Upgrade
|
Machinery | - | - | 1,069 | 817.66 | 582.7 | 384.94 | Upgrade
|
Construction In Progress | - | - | 460.54 | 256.9 | 96.49 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.